Literature DB >> 23649340

Suppression of inflammatory reactions by terpinen-4-ol, a main constituent of tea tree oil, in a murine model of oral candidiasis and its suppressive activity to cytokine production of macrophages in vitro.

Kentaro Ninomiya1, Kazumi Hayama, Sanae A Ishijima, Naho Maruyama, Hiroshi Irie, Junichi Kurihara, Shigeru Abe.   

Abstract

The onset of oral candidiasis is accompanied by inflammatory symptoms such as pain in the tongue, edema or tissue damage and lowers the quality of life (QOL) of the patient. In a murine oral candidiasis model, the effects were studied of terpinen-4-ol (T-4-ol), one of the main constituents of tea tree oil, Melaleuca alternifolia, on inflammatory reactions. When immunosuppressed mice were orally infected with Candida albicans, their tongues showed inflammatory symptoms within 24 h after the infection, which was monitored by an increase of myeloperoxidase activity and macrophage inflammatory protein-2 in their tongue homogenates. Oral treatment with 50 µL of 40 mg/mL terpinen-4-ol 3h after the Candida infection clearly suppressed the increase of these inflammatory parameters. In vitro analysis of the effects of terpinen-4-ol on cytokine secretion of macrophages indicated that 800 µg/mL of this substance significantly inhibited the cytokine production of the macrophages cultured in the presence of heat-killed C. albicans cells. Based on these findings, the role of the anti-inflammatory action of T-4-ol in its therapeutic activity against oral candidiasis was discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23649340     DOI: 10.1248/bpb.b13-00033

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  7 in total

1.  The antimicrobial and antiadhesion activities of micellar solutions of surfactin, CTAB and CPCl with terpinen-4-ol: applications to control oral pathogens.

Authors:  Andreia R Bucci; Larissa Marcelino; Renata K Mendes; Augusto Etchegaray
Journal:  World J Microbiol Biotechnol       Date:  2018-06-06       Impact factor: 3.312

2.  Essential oil of Melaleuca alternifolia for the treatment of oral candidiasis induced in an immunosuppressed mouse model.

Authors:  Vanessa Maria de Campos Rasteiro; Anna Carolina Borges Pereira da Costa; Cássia Fernandes Araújo; Patrícia Pimentel de Barros; Rodnei Dennis Rossoni; Ana Lia Anbinder; Antonio Olavo Cardoso Jorge; Juliana Campos Junqueira
Journal:  BMC Complement Altern Med       Date:  2014-12-15       Impact factor: 3.659

3.  Anti-inflammatory and gastroprotective potential of leaf essential oil of Cinnamomum glanduliferum in ethanol-induced rat experimental gastritis.

Authors:  Samar S Azab; Gehad A Abdel Jaleel; Omayma A Eldahshan
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 4.  Anticonvulsant Essential Oils and Their Relationship with Oxidative Stress in Epilepsy.

Authors:  Diogo Vilar da Fonsêca; Carlos da Silva Maia Bezerra Filho; Tamires Cardoso Lima; Reinaldo Nóbrega de Almeida; Damião Pergentino de Sousa
Journal:  Biomolecules       Date:  2019-12-06

5.  Pirfenidone suppresses polarization to M2 phenotype macrophages and the fibrogenic activity of rat lung fibroblasts.

Authors:  Michihito Toda; Shinjiro Mizuguchi; Yukiko Minamiyama; Hiroko Yamamoto-Oka; Takanori Aota; Shoji Kubo; Noritoshi Nishiyama; Toshihiko Shibata; Shigekazu Takemura
Journal:  J Clin Biochem Nutr       Date:  2018-04-11       Impact factor: 3.114

Review 6.  Efficacy of Toluidine Blue-Mediated Antimicrobial Photodynamic Therapy on Candida spp. A Systematic Review.

Authors:  Rafał Wiench; Dariusz Skaba; Jacek Matys; Kinga Grzech-Leśniak
Journal:  Antibiotics (Basel)       Date:  2021-03-25

Review 7.  Meta-analysis of the antifungal activities of three essential oils as alternative therapies in dermatophytosis infections.

Authors:  Julia Villar Rodríguez; Ana María Pérez-Pico; Esther Mingorance-Álvarez; Raquel Mayordomo Acevedo
Journal:  J Appl Microbiol       Date:  2022-03-31       Impact factor: 4.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.